Uranium Gets a Catalyst
Cameco is a winner in Japan's decision to restart its reactors.
Welcome news arrived Friday for moribund uranium markets and miner Cameco (CCJ)/(CCO), as the governor of Kagoshima approved what will be the first restarts of Japan's dormant reactor fleet: Sendai units 1 and 2. This follows the municipal government's Oct. 28 approval and sets the stage for restarts next year.
We expect roughly half of Japan's 48 functional reactors will eventually re-enter service, as economic imperatives overcome health and environmental concerns. Along with a wave of new builds in China and other emerging markets, uranium demand growth over the next decade should be the strongest since Chernobyl. Set against a continued drawdown of finite uranium inventories and underinvestment in mines due to low prices, we expect uranium prices to perform strongly though the end of the decade.
Daniel Rohr does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.